image
Sonoma Pharmaceuticals, Inc. SNOA
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 2.5601
-1.91 %
$ 3.43 M
Market Cap
-2.59
P/E
BALANCE SHEET
14.7 M ASSETS
-9.19%
Growth Rates
1Year -9.19%
3Years -0.55%
5Years 0.40%
7Years -7.51%
10Years -3.38%
8.6 M LIABILITIES
4.23%
Growth Rates
1Year 4.23%
3Years -3.67%
5Years 16.79%
7Years 11.45%
10Years -0.14%
6.14 M EQUITY
-23.07%
Growth Rates
1Year -23.07%
3Years 4.60%
5Years -10.17%
7Years -16.36%
10Years -6.53%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Sonoma Pharmaceuticals, Inc.
image
Current Assets 12.5 M
Cash & Short-Term Investments 3.13 M
Receivables 2.9 M
Other Current Assets 6.52 M
Non-Current Assets 2.19 M
Long-Term Investments 0
PP&E 651 K
Other Non-Current Assets 1.54 M
Current Liabilities 3.72 M
Accounts Payable 607 K
Short-Term Debt 719 K
Other Current Liabilities 2.39 M
Non-Current Liabilities 4.88 M
Long-Term Debt 87 K
Other Non-Current Liabilities 4.8 M

Balance Sheet

Millions
Mar-2024 Mar-2023 Mar-2022 Mar-2021 Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016 Mar-2015 Mar-2014 Mar-2013 Mar-2012 Mar-2011 Mar-2010 Mar-2009 Mar-2008 Mar-2007 Mar-2006 Mar-2005 Mar-2003 Mar-2002
ASSETS
Cash & Cash Equivalents 3.1 3.8 7.4 4.2 3.7 3.7 10.1 17.5 7.5 6.1 5.5 7.9 3.4 4.4 6.3 1.9 18.8 19.1 7.4 3.3 0.2 0.8
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 2.9 2.6 2.4 2.8 4.0 3.5 1.5 2.1 1.5 1.5 2.3 1.7 2.2 2.1 1.4 0.9 0.8 1.4 1.8 0.2 0 0
Inventory 2.7 2.9 2.7 2.5 2.2 3.4 2.9 2.2 1.6 1.4 1.1 1.0 1.0 0.7 0.6 0.3 0.3 0.3 0.3 0.9 0 0
Other Current Assets 3.8 4.5 4.0 3.4 2.4 1.9 1.8 0.9 2.3 0.6 0.6 0.9 0.5 0.6 0.8 0.8 1.1 3.2 0.7 0.5 0 0
Total Current Assets 12.5 13.8 16.4 13.0 12.4 12.5 16.3 22.6 12.9 9.6 9.5 11.5 7.0 7.8 9.1 3.9 20.9 23.9 10.2 4.9 0.2 0.8
PP&E 0.7 0.9 0.9 1.1 1.3 0.7 1.1 1.2 0.8 0.8 1.0 0.8 0.8 0.8 1.1 1.4 2.3 2.2 1.9 2.0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 4.5 10.2 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.4 0.6 0.7 0.9 0.8 1.2 1.8 1.6 65 K 68 K 0.1 0.2 72 K 53 K 60 K 73 K 0.4 0.9 0.5 100 K 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.0 0
Total Assets 14.7 16.2 18.8 15.0 14.6 14.4 19.2 25.5 13.8 15.0 20.8 12.6 7.8 8.7 10.2 5.4 23.6 26.9 12.7 6.9 1.0 1.7
LIABILITIES
Accounts Payable 0.6 0.8 1.6 1.8 2.1 1.3 1.3 1.3 1.3 0.9 0.7 0.8 0.8 0.7 1.0 1.6 3.0 2.6 2.8 0.9 0 0
Short Term Debt 0.7 0.9 1.1 1.1 0.6 0.5 0.4 0.2 0.1 87 K 0.1 1.3 1.4 0.9 0.2 0.3 2.0 6.1 0.5 1.0 0 0
Other Current Liabilities (2.8) (2.5) (2.0) (2.6) 2.5 1.8 2.0 1.9 2.1 0.8 4.1 0.7 0.8 1.0 1.2 0.8 2.5 1.4 1.7 2.3 0 0
Total Current Liabilities 3.7 3.7 5.8 4.1 4.9 3.6 3.3 3.3 3.6 2.6 7.6 5.1 4.7 4.4 2.7 2.7 7.5 10.0 5.1 4.2 0 0
Long Term Debt 87 K 0.2 0.3 1.8 0.2 12 K 0.2 0.2 0 0 4 K 0.7 1.8 1.6 0.1 74 K 0.2 2.0 0.3 0.5 0 0
Deferred Tax Income 0 0.2 0.3 0 (3.7) 12 K (0.1) (0.2) 0 0 (1.2) 0 0 0 (0.3) (0.4) 0.5 0 0 0 0 0
Other Liabilities 4.7 4.2 3.8 3.5 3.7 0 0 0 0 0 0 62 K 2.0 0.8 0 0 0 0 0 0 0 0
Total Liabilities 8.6 8.3 10.1 9.6 5.9 4.0 3.9 4.0 3.7 3.0 8.7 8.5 8.7 7.0 3.2 3.2 8.2 12.0 5.4 4.7 1.0 0
EQUITY
Common Stock 2 K 5 K 2 K 2 K 2 K 2 K 1 K 1 K 2 K 2 K 1 K 1 K 3 K 3 K 3 K 2 K 2 K 1 K 3.4 3.1 0 0
Retained Earnings (194.3) (189.5) (184.4) (179.3) (172.2) (169.2) (157.4) (143.1) (152.4) (142.2) (134.0) (137.7) (132.3) (125.0) (117.0) (108.5) (90.8) (70.5) (50.3) (27.1) 0 0
Other Accumulative Comprehensive Income/Loss (2.7) (3.4) (4.3) (4.6) (5.6) (4.3) (4.0) (4.2) (3.9) (3.5) (3.1) (3.0) (3.1) (2.9) (3.0) (3.1) (2.8) (0.4) (0.8) (0.8) 0 0
Total Equity 6.1 8.0 8.7 5.4 8.7 10.5 15.3 21.4 10.1 12.1 12.1 4.1 (0.9) 1.7 7.0 2.3 15.4 14.9 7.3 2.2 79 K 0.9
Total Liabilities and Equity 14.7 16.2 18.8 15.0 14.6 14.4 19.2 25.5 13.8 15.0 20.8 12.6 7.8 8.7 10.2 5.4 23.6 26.9 12.7 6.9 1.0 1.7
SHARES OUTSTANDING
Common Shares Outstanding 0.5 0.2 0.1 99.8 K 73.8 K 46.2 K 25.2 K 23.5 K 18.3 K 10.7 K 7.65 K 5.53 K 4.35 K 4.19 K 3.65 K 2.57 K 2.02 K 865 659 621 621 607 602